Kevin J. Scanlon, Ph.D. Email and Phone Number
Kevin J. Scanlon, Ph.D. work email
- Valid
- Valid
- Valid
Kevin J. Scanlon, Ph.D. personal email
- Valid
Kevin J. Scanlon, Ph.D. phone numbers
Dr. Kevin Scanlon’s career spans roles in academic medicine, senior management in the pharmaceutical industry and biotech companies, as well as an individual investor. Dr. Scanlon was identified by LA Techweek as an individual impacting the Los Angeles business and the technology landscape on a significant scale.During the two years Dr. Scanlon served as the Chairman of Pasadena Angels Investment Group, ~100 investors funded over 50 companies. He has been CEO of four biotechnology companies, including Melanoma Diagnostics, which was sold to Myriad Genetics. At Berlex-Schering AG (Berlin, Germany), he was responsible for the genomic and cancer programs in the US, Europe and Asia.Dr. Scanlon’s notable academic achievements include: Leukemia Society Scholar, Paul Martini Medical Research Prize (Germany), Co-Founder and Co-Editor of the Nature Journal “Cancer Gene Therapy”, President of the International Society of Cell and Gene Therapy, co-authoring 139 peer-reviewed scientific articles and nine medical books. Dr. Scanlon also holds seven issued US Patents.He is also the author of "The Hybrid Entrepreneur" (Amazon.com).Specialties: Life Science, Biotechnology, management and sciences
-
Founder And CeoInternational BiosciencePasadena, Ca, Us
-
Chairman EmeritusPasadena Angels Jul 2014 - PresentPasadena, California, UsThe Pasadena Angel Investment Group has SEC accredited investors for funding novel technology with over 100 accomplished professionals. Our members have a wealth of talent, experience, and a strong business network. The Pasadena Angels was formed in the spring of 2000 by our founder, DuWayne Peterson, based on the core belief that the best way to help emerging companies is to harness the expertise and capital from a group of informed and connected investors. We have consistently been recognized as one of the top angel investing groups in the US, by Forbes and the Angel Research Institute, Entrepreneur among others.
-
Director And ChairmanPasadena Angels 2004 - Dec 2014Pasadena, California, UsChairman Emeritus of the Pasadena Angel Investment Group. We are SEC accredited investors funding new technology. The Pasadena Angels are over 100 accomplished professionals with a wealth of talent, experience and relationships. Investments total over $50 million in over 120 early stage ventures. Members contribute human and financial capital to build successful early-stage technology companies. The Angels work closely with a company, in concert with a network of venture capitalists and incubators, to contribute to the company's success.
-
Founder And CeoInternational Bioscience Jun 2004 - PresentThe role of International BioScience is to be a catalyst that bridges the worlds of academia, industry and venture capital. These services have been provided to the governments in Ireland, New Zealand and China. The nurturing of creative scientific ideas, coupled with sound business plans will ultimately help transition concepts into commercial reality that will benefit mankind.
-
Investment AdvisorSky Venture Group Jun 2015 - Jul 2022Sky Ventures Group has launched in Boston, (2015) with plans to provide seed funding to early stage life science and healthcare companies. It holds monthly investor meetings, during which four vetted startups will pitch their concepts to the group. Currently it consists of more than 126 angel investors, 27 corporate investors, family offices and more who meet to gauge whether they want to help seed a company. Sky Ventures managing partner is Eyal Geffen. Sky Ventures Group says it’ll front between $100,000 and $4 million in seed investments across the life sciences and healthcare. It’s interested in biotech, pharma, medical devices, diagnostics, digital health, health IT, mobile healthcare, healthcare services and industrial biotech.
-
Professor Of PracticeD’Amore-Mckim School Of Business At Northeastern University Jul 2016 - Jun 2022Boston, Massachusetts, UsEntrepreneurial Venture Growth Strategies (a CAP Stone Course): This course focuses on helping Northeastern ventures improve their strategies to achieve external funding. The course teaches frameworks for target markets, customer segmentation, product and service design and validations, team assessments, as well as business and financial models. The students (~600) have applied these methods to improve the business plans for these early stage ventures. Working in teams, students design and administer customer surveys, create detailed financial projections, and create investor packages. This includes a due diligence package, a term sheet, and a PowerPoint presentation for investors. University companies (~100) have been taken from multiple areas from across the University, including different technologies and services. Overall, the course is a practicum on what it takes to get new venture concepts funded. The students learn the perspective of the entrepreneur, the customer, and the investor. -
Entrepreneur In ResidenceNortheastern University D'Amore-Mckim Jul 2015 - Jul 2016
-
Executive CommitteeTech Coast Angels Sep 2004 - Feb 2014Irvine, California, Us -
Co-Founder And CeoMelanoma Diagnostics Aug 2006 - Aug 2011Melanoma Diagnostics, Inc. is a molecular diagnostics company whose proprietary, patent-pending technology from the University of California San Francisco (UCSF) is unique for evaluating malignant melanoma (skin cancer). This novel technology includes a number of highly validated genetic markers, allowing it to discriminate between normal and melanoma (cancer) cells. The markers developed by Melanoma Diagnostics allow pathologists to discriminate between benign moles and melanoma, and to better characterize the risk of disease progression or metastasis. The company was sold to Myriad Genetics in December 2010.
-
Vice PresidentBerlex/Schering Ag Mar 1996 - Jan 2000I was responsible for the Cancer Program in Europe, Asia and the United States for Berlex/Schering AG in Berlin, Germany
Kevin J. Scanlon, Ph.D. Skills
Kevin J. Scanlon, Ph.D. Education Details
-
Yale School Of MedicineOncology And Cancer Biology -
University Of LondonMolecular Biology
-
Sacred Heart UniversityBachelor Of Science (B.Sc.)
Frequently Asked Questions about Kevin J. Scanlon, Ph.D.
What company does Kevin J. Scanlon, Ph.D. work for?
Kevin J. Scanlon, Ph.D. works for International Bioscience
What is Kevin J. Scanlon, Ph.D.'s role at the current company?
Kevin J. Scanlon, Ph.D.'s current role is Founder and CEO.
What is Kevin J. Scanlon, Ph.D.'s email address?
Kevin J. Scanlon, Ph.D.'s email address is kj****@****ink.net
What is Kevin J. Scanlon, Ph.D.'s direct phone number?
Kevin J. Scanlon, Ph.D.'s direct phone number is (800) 969*****
What schools did Kevin J. Scanlon, Ph.D. attend?
Kevin J. Scanlon, Ph.D. attended Yale School Of Medicine, University Of London, Sacred Heart University.
What skills is Kevin J. Scanlon, Ph.D. known for?
Kevin J. Scanlon, Ph.D. has skills like Start Ups, Entrepreneurship, Biotechnology, Venture Capital, Executive Management, Life Sciences, Angel Investing, Business Strategy, Strategic Planning, Strategic Partnerships, Corporate Development, Business Planning.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial